Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression-Reference-Cited by-同舟云学术

Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression

Published:2018-08-02 Issue: Volume: Page:
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Huang Raymond Y¹,Unadkat Prashin¹,Bi Wenya Linda²,George Elizabeth¹,Preusser Matthias³,McCracken Jay D⁴,Keen Joseph R⁵,Read William L⁴,Olson Jeffrey J⁴,Seystahl Katharina⁶,Le Rhun Emilie⁷⁸,Roelcke Ulrich⁹,Koeppen Susanne¹⁰,Furtner Julia¹¹,Weller Michael⁶,Raizer Jeffrey J¹²,Schiff David¹³,Wen Patrick Y¹⁴

Affiliation:

1. Department of Radiology, Brigham and Women’s Hospital, Boston, Massachusetts, USA

2. Center for Skull Base and Pituitary Surgery, Department of Neurosurgery, Brigham and Women’s Hospital, Boston, Massachusetts, USA

3. Clinical Division of Oncology, Department of Medicine I, Comprehensive Cancer Centre, Medical University Vienna‒General Hospital, Vienna, Austria

4. Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia, USA

5. Department of Neurosurgery, Ochsner Medical Center, New Orleans, Louisiana, USA

6. Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland

7. University of Lille, Lille, France; Inserm, U-1192, Lille, France; CHU Lille, General and Stereotaxic Neurosurgery Service, Lille, France

8. Oscar Lambret Center, Neurology, Medical Oncology Department, Lille, France

9. Department of Neurology and Brain Tumor Center Cantonal Hospital, Aarau, Switzerland

10. Department of Neurology Clinic, Essen Medical Center, Essen, Germany

11. Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria

12. Medical Neuro-Oncology, Northwestern Medicine, Chicago, Illinois, USA

13. Departments of Neurology, Neurological Surgery, and Medicine, University of Virginia, Charlottesville, Virginia, USA

14. Center For Neuro-Oncology, Dana-Farber/Brigham and Women’s Cancer Center, Boston, Massachusetts, USA

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noy126/25678632/noy126.pdf

Reference20 articles.

1. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014;Ostrom;Neuro Oncol,2017

2. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma;Aizer;Neuro Oncol,2014

3. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients;Stafford;Neurosurgery,2001

4. Medical therapies for meningiomas;Wen;J Neurooncol,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital “flipbooks” for enhanced visual assessment of simple and complex brain tumors;Neuro-Oncology;2024-05-29

2. Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients;Neuro-Oncology;2024-05-02

3. 3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas;Neuro-Oncology;2024-03-07

4. Comparison of Volumetric and 2D Measurements and Longitudinal Trajectories in the Response Assessment ofBRAFV600E-Mutant Pediatric Gliomas in the Pacific Pediatric Neuro-Oncology Consortium Clinical Trial;American Journal of Neuroradiology;2024-03-07

5. Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study;Journal of Nuclear Medicine;2024-02-29